1-9 of 9
Giuseppe Daniele
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin

Available to Purchase
Giuseppe Daniele, Andrea Tura, Alex Brocchi, Alessandro Saba, Beatrice Campi, Veronica Sancho-Bornez, Angela Dardano, Stefano Del Prato
Journal: Diabetes Care
Diabetes Care 2024;47(7):1131–1139
https://doi.org/10.2337/dc23-2051
Published: 23 April 2024
View articletitled, β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
Open the PDF for β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin in another window
Journal Articles

Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients

Free
Siham Abdelgani, Ahmed Khattab, John Adams, Mohamed Abu-Farha, Giuseppe Daniele, Fahd Al-Mulla, Stefano Del Prato, Ralph A. DeFronzo, Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2023;46(5):978–984
https://doi.org/10.2337/dc22-0885
Published: 01 March 2023
View articletitled, Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Open the PDF for Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients in another window
Journal Articles

Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141

Free
Monia Garofolo, Elisa Gualdani, Cristina Bianchi, Michele Aragona, Fabrizio Campi, Daniela Lucchesi, Giuseppe Daniele, Roberto Miccoli, Paolo Francesconi, Stefano Del Prato, Giuseppe Penno
Journal: Diabetes Care
Diabetes Care 2021;44(4):e81
https://doi.org/10.2337/dci20-0079
Published: 15 March 2021
View articletitled, Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141
Open the PDF for Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141 in another window
Journal Articles

Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study

Free
Monia Garofolo, Elisa Gualdani, Maria Giovanna Scarale, Cristina Bianchi, Michele Aragona, Fabrizio Campi, Daniela Lucchesi, Giuseppe Daniele, Roberto Miccoli, Paolo Francesconi, Stefano Del Prato, Giuseppe Penno
Journal: Diabetes Care
Diabetes Care 2020;43(10):e139–e141
https://doi.org/10.2337/dc20-0433
Published: 13 August 2020
View articletitled, Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study
Open the PDF for Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study in another window
Journal Articles

Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion

Free
Carolina Solis-Herrera, Giuseppe Daniele, Mariam Alatrach, Christina Agyin, Curtis Triplitt, John Adams, Rupal Patel, Amalia Gastaldelli, Henri Honka, Xi Chen, Muhammad Abdul-Ghani, Eugenio Cersosimo, Stephano Del Prato, Ralph DeFronzo
Journal: Diabetes Care
Diabetes Care 2020;43(5):1065–1069
https://doi.org/10.2337/dc19-2177
Published: 06 March 2020
View articletitled, Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion
Open the PDF for Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion in another window
Includes: Supplementary data
Journal Articles

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Free
Giuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, Aurora Merovci, Roy Eldor, Devjit Tripathy, Ralph A. DeFronzo, Luke Norton, Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2016;39(11):2036–2041
https://doi.org/10.2337/dc15-2688
Published: 25 August 2016
View articletitled, Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
Open the PDF for Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes in another window
Journal Articles

Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects

Free
Roy Eldor, Giuseppe Daniele, Claudia Huerta, Mariam Al-Atrash, John Adams, Ralph DeFronzo, Timothy Duong, John Lancaster, Mahmoud Zirie, Amin Jayyousi, Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2016;39(10):1804–1810
https://doi.org/10.2337/dc15-2706
Published: 03 August 2016
View articletitled, Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects
Open the PDF for Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects in another window
Journal Articles

Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism

Free
Giuseppe Daniele, Deidre Winnier, Andrea Mari, Jan Bruder, Marcel Fourcaudot, Zuo Pengou, Devjit Tripathy, Christopher Jenkinson, Franco Folli
Journal: Diabetes Care
Diabetes Care 2015;38(8):1509–1517
https://doi.org/10.2337/dc14-2989
Published: 18 June 2015
View articletitled, Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism
Open the PDF for Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism in another window
Includes: Supplementary data
Journal Articles

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes

Open Access
Cristina Bianchi, MD, Roberto Miccoli, MD, Giuseppe Daniele, MD, Giuseppe Penno, MD, Stefano Del Prato, MD
Journal: Diabetes Care
Diabetes Care 2009;32(suppl_2):S342–S348
https://doi.org/10.2337/dc09-S336
Published: 01 November 2009
View articletitled, Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
Open the PDF for Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes in another window